Press Releases

The latest updates from our team


The Science of Adult Stem Cells

Background information on the science behind our work


In the News

Current news regarding stem cell research

Media

Media contact information


Press Releases

Fate Therapeutics Taps Successful Biotech CEOs Paul Grayson and John Mendlein for Leadership Team

Fate Therapeutics Created by Leading Stem Cell Scientists to Pursue New Approaches to Stem Cell Therapies

 



The Science of Adult Stem Cells


Stem Cells in the News

Forbes: Regenerators
Seattle Post-Intelligencer: Adult stem cell startup Fate Therapeutics scores $12 million
Puget Sound Business Journal: Scientists form new Seattle biotech, backed by $12M
BioWorld Today: A Different Approach To Stem Cell Therapy:Fate Tempts VCs With Viable Stem Cell Business Model
Mass High Tech: Hub biotech biggies launch new stem cell startup


Media

Thank you for inquiring about the work of Fate Therapeutics.  Please contact Sam Butler at Edelman Seattle, sam.butler@edelman.com or 206-268-2255 for more information.

About Fate Therapeutics

Fate Therapeutics was founded by the world’s leading experts in adult stem cell biology to develop and commercialize therapies to control the destiny of cells. The company’s revolutionary platforms are focused on developing medicines that awaken adult stem cells resident within the body to fight disease and regenerate damaged cells and tissue, and on the use of small molecules to reprogram mature adult cells to an embryonic-like state. The company’s work has broad application, and offers new hope in the treatment of degenerative diseases, developmental disorders, and cancer and in enabling the creation of patient-identical cells for transplantation.Fate has facilities in Seattle, and soon in California and Massachusetts.


 


Fate Therapeutics © 2007